Drug & Supplement Interactions
Transfer Factor + Cemiplimab-Rwlc
Brand name of Cemiplimab-Rwlc
- Libtayo
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team
Updated July 2026Details about this page
- Pair last verified Nov 22, 2026
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- Editorial policy
- Our sources →
AI is used only to summarize verified clinical information, never the open internet. Our AI policy
We found no known interaction between Transfer Factor and Cemiplimab-Rwlc in our sources.
This also applies to Libtayo, a brand name of Cemiplimab-Rwlc.
Still Worth Knowing
- Shared side effects: Although there is no interaction, both can cause some of the same side effects. Taken together, those side effects might add up, and a new symptom can be harder to pin on one or the other.
Ask a Question About This Combination
Ask in your own words about taking Transfer Factor with Cemiplimab-Rwlc. The answer comes from this page’s own records.
AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI
Transfer Factor and Cemiplimab-Rwlc Interaction Check
No Known Interaction Found
We did not find a documented interaction between Cemiplimab-Rwlc and Transfer Factor in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.
How We Checked
Why No Interaction Is Listed for Cemiplimab-Rwlc
Neither one has a record. Our interaction database holds no record for Transfer Factor with any drug, and none for Cemiplimab-Rwlc with any supplement, so this rests on missing data, not on a study that found nothing.
Before You Combine Them
Taking Transfer Factor and Cemiplimab-Rwlc Together
- Add one new thing at a time, and note the date you started it.
- A start date turns “I’ve been feeling off” into something a pharmacist can work with.
- Do not stop a prescribed medicine on your own.
- Check with your pharmacist or doctor before changing any medicine or supplement, especially if you take several or have an ongoing health condition.
Using Transfer Factor for the Same Condition as Cemiplimab-Rwlc
Why This Matters
- The same goal. Cemiplimab-Rwlc is prescribed for lung cancer, and Transfer Factor has been studied for it too.
- It might help, or it might go too far. If Transfer Factor does work for it, the two effects might add up. That might mean better control, or it might go further than intended.
- Tell your prescriber. A graded use is not a treatment, so do not stop or replace Cemiplimab-Rwlc on your own. If you take Transfer Factor for the same reason, your prescriber may want to keep a closer eye on how Cemiplimab-Rwlc is working.
Cemiplimab-Rwlc is a prescription medicine with approved uses on its FDA label. Transfer Factor is a supplement: here is what researchers have looked at it for, and how strong that evidence is.
From the FDA Label
Cemiplimab-Rwlc Is Prescribed For
Libtayo (cemiplimab-rwlc) is used in adults to treat certain cancers. These include cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer.
Read the rest of what Cemiplimab-Rwlc is prescribed for
Each use has specific conditions, such as prior surgery or radiation, prior treatment, or tumor testing. Your cancer team decides whether it fits your situation.
From the Natural Medicines Research Record
Transfer Factor Has Been Studied For
-
Lung cancer
Studied, Not Established
Read what the research shows
Most research shows that administering human-derived transfer factor intramuscularly or subcutaneously, in combination with lung resection and chemotherapy, does not increase survival in patients with lung cancer. However, some preliminary evidence suggests that transfer factor might improve survival in lung cancer patients with Stage IIIA or IIIB disease.
4 references cited
- 5447. Whyte RI, Schork MA, Sloan H, et al. Adjuvant treatment using transfer factor for bronchogenic carcinoma: long-term follow-up. Ann Thorac Surg 1992;53:391-6. PubMed
- 7800. Fujisawa T, Yamaguchi Y, Kimura H, et al. Adjuvant immunotherapy of primary resected lung cancer with transfer factor. Cancer 1984;54:663-9. PubMed
- 78793. Fujisawa, T., Yamaguchi, Y., Kimura, H., Arita, M., Shiba, M., and Baba, M. Randomized controlled trial of transfer factor immunochemotherapy as an adjunct to surgical treatment for primary adenocarcinoma of the lung. Jpn.J.Surg. 1984;14(6):452-458. PubMed
- 78824. Pilotti, V., Mastrorilli, M., Pizza, G., De, Vinci C., Busutti, L., Palareti, A., Gozzetti, G., and Cavallari, A. Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapy. Biotherapy 1996;9(1-3):117-121. PubMed
The grades and the research summaries are from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”.
Get to Know Each One
About Transfer Factor and Cemiplimab-Rwlc
About Transfer Factor
Transfer factors are small immune molecules taken from cow colostrum or egg yolk and sold as supplements meant to boost or 'train' the immune system. Solid human evidence for the supplement products is limited, and quality varies widely between brands. Talk with your pharmacist or doctor before using one, especially if you have an immune condition.
How Transfer Factor Is Rated
-
Transfer Factor Overall
Use caution
Generally well tolerated in studies, but long-term safety and product quality are not well established.
-
Pregnancy
Avoid
Safety has not been established, so it is best avoided during pregnancy.
-
Breastfeeding
Avoid
Not enough safety information exists, so avoid while breastfeeding.
About Cemiplimab-rwlc Injection
Brand name: Libtayo
Libtayo (cemiplimab-rwlc) is used in adults to treat certain cancers. These include cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer.
More to Explore
More Pairs and Interactions to Check
Other Supplements People Check With Cemiplimab-Rwlc
More pair pages for Cemiplimab-Rwlc: the rest of its documented supplement interactions first, then supplements with none on record, the most looked-up leading.
- Vitamin CNo Known Interaction›
- CalciumNo Known Interaction›
- Vitamin B6No Known Interaction›
- MagnesiumNo Known Interaction›
- Vitamin DNo Known Interaction›
- Vitamin B12No Known Interaction›
Show all 30 supplementsShow fewer
- ZincNo Known Interaction›
- SodiumNo Known Interaction›
- Vitamin ENo Known Interaction›
- Vitamin ANo Known Interaction›
- RiboflavinNo Known Interaction›
- PotassiumNo Known Interaction›
- BiotinNo Known Interaction›
- SeleniumNo Known Interaction›
- Pantothenic AcidNo Known Interaction›
- LaxogeninNo Known Interaction›
- Lemon EucalyptusNo Known Interaction›
- Lemon VerbenaNo Known Interaction›
- LentinanNo Known Interaction›
- Lesser CelandineNo Known Interaction›
- Levant BerryNo Known Interaction›
- Levilactobacillus BrevisNo Known Interaction›
- LigandrolNo Known Interaction›
- Ligilactobacillus SalivariusNo Known Interaction›
- Lily-of-the-valleyNo Known Interaction›
- LimoneneNo Known Interaction›
- Limosilactobacillus FermentumNo Known Interaction›
- Limosilactobacillus ReuteriNo Known Interaction›
- LindenNo Known Interaction›
- LingonberryNo Known Interaction›
Other Drugs & Transfer Factor
Browse every other medication we’ve checked against Transfer Factor — both the ones with a known interaction and the ones without. Select any drug for the full detail.
No drugs match “”.
Also checked against Transfer Factor
No Interaction 2,829 drugs checked — show the list
We also checked Transfer Factor against these medications and found no known interaction in our sources. Open any page to confirm.
- Apixaban ›
- Warfarin ›
- Levothyroxine ›
- Amlodipine ›
- Sertraline ›
- Clopidogrel ›
- Rosuvastatin ›
- Losartan Potassium ›
- Aspirin ›
- Atorvastatin ›
- Escitalopram ›
- Levothyroxine and Liothyronine ›
- Warfarin Sodium ›
- Rivaroxaban ›
- Metformin ›
- Metoprolol ›
- Tirzepatide ›
- Methylphenidate ›
- Tadalafil ›
- Ibuprofen ›
- Semaglutide ›
- Ivermectin ›
- Testosterone ›
- Fluoxetine ›
- Amoxicillin ›
- Prednisone ›
- Acetaminophen ›
- Amphetamine ›
- Azithromycin ›
- Isotretinoin ›
- Benralizumab ›
- Benzalkonium Chloride ›
- Benznidazole ›
- Benzocaine ›
- Benzocaine/menthol ›
- Benzonatate ›
- Benzoyl Peroxide ›
- Benzphetamine ›
- Benzthiazide ›
- Benztropine ›
- Benzyol Peroxide ›
- Bepridil ›
- Berdazimer ›
- Berotralstat Hydrochloride ›
- Betahistine Dihcl ›
- Betamethasone ›
- Betamethasone Dipropionate ›
- Betamethasone Valerate ›
- Betaxolol ›
- Bethanechol Chloride ›
- Betrixaban ›
- Bevacizumab ›
- Bevacizumab-awwb ›
- Bevacizumab-bvzr ›
- Bexarotene ›
- Bezafibrate ›
- Bezlotoxumab ›
- Bicalutamide ›
- Bimatoprost ›
- Bimekizumab-bkzx ›
Showing 60 of the 2,829 medications checked with no known interaction, the most looked-up first — see the full Transfer Factor list.
Where Transfer Factor and Cemiplimab-Rwlc Sit Against Everything Else
Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.
#727 of 1,458 supplements looked up here in the last 7 days
#1,680 of 2,830 medications looked up here in the last 7 days
A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.
Keep Exploring
Questions and Sources
Common Questions and Where This Comes From
Taking Transfer Factor and Cemiplimab-Rwlc Together: Common Questions
Can you take Transfer Factor with Cemiplimab-Rwlc?
Can you take Transfer Factor with Libtayo?
Do Transfer Factor and Cemiplimab-Rwlc have any of the same side effects?
Are Transfer Factor and Cemiplimab-Rwlc used for the same thing?
Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy
References Cited on This Page
The 15 references the cards above cite, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.
Show the 15 references
- 350. Jones JF, Minnich LL, Jeter WS, et al. Treatment of childhood combined Epstein-Barr virus/cytomegalovirus infection with oral bovine transfer factor. Lancet 1981;2:122-4. PubMed
- 1445. Louie E, Borkowsky W, Klesius PH, et al. Treatment of cryptosporidiosis with oral bovine transfer factor. Clin Immunol Immunopathol 1987;44:329-34. PubMed
- 1507. Fudenberg HH. Transfer factor: past, present and future. Annu Rev Pharmacol Toxicol 1989;29:475-516. PubMed
- 1825. Lewis CJ. Letter to reiterate certain public health and safety concerns to firms manufacturing or importing dietary supplements that contain specific bovine tissues. FDA. Available at: www.cfsan.fda.gov/~dms/dspltr05.html.
- 3062. Miller LL, Spitler LE, Allen RE, Minor DR. A randomized, double-blind, placebo-controlled trial of transfer factor as adjuvant therapy for malignant melanoma. Cancer 1988;61:1543-9. PubMed
- 3063. Bukowski RM, Deodhar S, Hewlett JS, Greenstreet R. Randomized controlled trial of transfer factor in Stage II malignant melanoma. Cancer 1983;51:269-72. PubMed
- 5447. Whyte RI, Schork MA, Sloan H, et al. Adjuvant treatment using transfer factor for bronchogenic carcinoma: long-term follow-up. Ann Thorac Surg 1992;53:391-6. PubMed
- 7562. Lloyd AR, Hickie I, Brockman A, et al. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am J Med 1993;94:197-203. PubMed
- 7799. Fog T, Pedersen L, Raun NE, et al. Long-term transfer-factor treatment for multiple sclerosis. Lancet 1978;1:851-3. PubMed
- 7800. Fujisawa T, Yamaguchi Y, Kimura H, et al. Adjuvant immunotherapy of primary resected lung cancer with transfer factor. Cancer 1984;54:663-9. PubMed
- 78789. Thestrup-Pedersen, K., Grunnet, E., and Zachariae, H. Transfer factor therapy in mycosis fungoides: a double-blind study. Acta Derm.Venereol. 1982;62(1):47-53. DOI
- 78793. Fujisawa, T., Yamaguchi, Y., Kimura, H., Arita, M., Shiba, M., and Baba, M. Randomized controlled trial of transfer factor immunochemotherapy as an adjunct to surgical treatment for primary adenocarcinoma of the lung. Jpn.J.Surg. 1984;14(6):452-458. PubMed
- 78809. Fernandez, O., Diaz, N., Morales, E., Toledo, J., Hernandez, E., Rojas, S., Madriz, X., and Lopez, Saura P. Effect of transfer factor on myelosuppression and related morbidity induced by chemotherapy in acute leukaemias. Br.J.Haematol. 1993;84(3):423-427 PubMed
- 78820. De Vinci, C., Levine, P. H., Pizza, G., Fudenberg, H. H., Orens, P., Pearson, G., and Viza, D. Lessons from a pilot study of transfer factor in chronic fatigue syndrome. Biotherapy 1996;9(1-3):87-90. PubMed
- 78824. Pilotti, V., Mastrorilli, M., Pizza, G., De, Vinci C., Busutti, L., Palareti, A., Gozzetti, G., and Cavallari, A. Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapy. Biotherapy 1996;9(1-3):117-121. PubMed
All 49 references behind our Transfer Factor records are listed in the Transfer Factor guide.
Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is reviewed by the HelloPharmacist Editorial Team. See our data sources and editorial standards.
Where Does Our Data Come From?
- Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
- Citation library: 105,612 references behind our interaction content, 67,053 of them resolved to verified PubMed/DOI sources. See the references behind this page ↓
- Freshness: we automatically re-check this combination every week — this pair was last verified November 22, 2026. The Transfer Factor and Cemiplimab-Rwlc records this page draws on were last updated July 10, 2026.
What Our Interaction Ratings Mean
No interaction is on record for this pair. The other supplements and medicines on this page carry a severity rating: how serious an interaction between them is.
See what each severity means
Severity: How Serious Is It?
How clinically significant the interaction is: how much it could affect your health or your treatment.
- MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
- ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
- MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
- No Known InteractionNo documented interaction in our sources.
Still Have a Question About Transfer Factor and Cemiplimab-Rwlc?
Our pharmacists answer your medication & supplement questions — free.
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.